Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Last 14 days
Safety, Feasibility, and Biomarker Characterization Study of ATTN201 Repeated Centromedian Thalamic Nucleus Focused Ultrasound Stimulation for the Treatment of Chronic Pain
Bayesian-Optimized Dose-Finding of ATTN201 Focused Ultrasound for Behavioral Health
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)